Regulus Therapeutics Inc.

NASDAQ:RGLS

1.71 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011
Assets:
Current Assets:
Cash & Cash Equivalents 23.82924.22860.38331.08734.12113.93513.51976.111115.31937.327114.00540.5529.175
Short Term Investments 014.932000046.55561.1798.103122.41696.19857.54828.969
Cash and Short Term Investments 23.82939.1660.38331.08734.12113.93560.07476.111115.319159.743114.00598.138.144
Net Receivables -0.0033.0693.0690.5031.1410.0260.3731.65710.0210.2740.07900
Inventory 0.0030.0030.0033.3143.9244.1944.7835.552-10.0210-0.07900
Other Current Assets 1.341.8471.781.8261.2211.141.50611.36318.9394.9343.1770.8290.522
Total Current Assets 25.16944.07965.23536.7340.40719.29566.73687.474134.258164.951117.18298.92938.666
Non-Current Assets:
Property, Plant & Equipment, Net 2.5382.5752.8450.4720.9217.8069.70811.835.43.5683.7683.313.11
Goodwill 0000000000000
Intangible Assets 0.0330.0620.0830.1250.2660.50.7751.0151.0811.151.1281.1540.98
Goodwill and Intangible Assets 0.0330.0620.0830.1250.2660.50.7751.0151.0811.151.1281.1540.98
Long Term Investments 0000000000000
Tax Assets 0000000000000
Other Non-Current Assets 3.0100.2910.2770.4870.3260.590.3420.3441.8110.9870.1250.125
Total Non-Current Assets 5.5812.6373.2190.8741.6748.63211.07313.1876.8256.5295.8834.5894.215
Total Assets 30.7546.71668.45437.60442.08127.92777.809100.661141.083171.48123.065103.51842.881
Liabilities & Equity:
Current Liabilities:
Account Payables 0.2040.1750.2850.5351.3211.7145.7435.842.7172.1881.1720.3110.501
Short Term Debt 2.0474.5110.5894.65214.63116.57519.859-0.072-1.19423.397-4.88800.377
Tax Payables 0000000000000.206
Deferred Revenue 00-0.5893.4210.0062.5720.0720.0721.1943.0974.88810.45110.735
Other Current Liabilities 6.2576.9714.9422.975.645.7856.9267.8958.721-19.9844.312.0061.237
Total Current Liabilities 8.50811.6575.22711.57821.59826.64632.613.73511.4388.6985.48212.76812.85
Non-Current Liabilities:
Long Term Debt 1.0551.7687.09000019.802023.39711.27910.13410.438
Deferred Revenue Non-Current 000000.0061.9212.0653.2596.34911.38817.75616.987
Deferred Tax Liabilities Non-Current 000000000000-0.438
Other Non-Current Liabilities 001.17900.4687.1298.0728.9842.3081.0221.4590.76744.538
Total Non-Current Liabilities 1.0551.7688.26900.4687.1359.99330.8515.56730.76824.12628.65771.525
Total Liabilities 9.56313.42513.49611.57822.06633.78142.59344.58617.00539.46629.60841.42584.375
Equity:
Preferred Stock 0.0050.0050.0050.0020.00400000000
Common Stock 0.020.0170.1460.0670.0210.0090.1040.0530.0530.0490.0420.0360
Retained Earnings -513.213-483.176-454.853-427.045-411.315-392.723-345.858-273.351-191.515-135.767-79.087-60.419-43.011
Accumulated Other Comprehensive Income/Loss -0.001-0.012000-9.894-0.134-0.123-0.133-0.197-0.016-0.052-0.067
Other Total Stockholders Equity 534.376516.457509.66453.002431.305396.754381.104329.496315.673267.929172.518122.5281.584
Total Shareholders Equity 21.18733.29154.95826.02620.015-5.85435.21656.075124.078132.01493.45762.093-41.494
Total Equity 21.18733.29154.95826.02620.015-5.85435.21656.075124.078132.01493.45762.093-41.494
Total Liabilities & Shareholders Equity 30.7546.71668.45437.60442.08127.92777.809100.661141.083171.48123.065103.51842.881